AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)

Historic Construction in Progress for AbCellera Biologics (ABCL) over the last 3 years, with Q3 2025 value amounting to $118.7 million.

  • AbCellera Biologics' Construction in Progress rose 2763.44% to $118.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year increase of 2763.44%. This contributed to the annual value of $103.2 million for FY2024, which is 1340.66% up from last year.
  • Per AbCellera Biologics' latest filing, its Construction in Progress stood at $118.7 million for Q3 2025, which was up 2763.44% from $116.0 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Construction in Progress registered a high of $118.7 million during Q3 2025, and its lowest value of $10.5 million during Q2 2023.
  • In the last 3 years, AbCellera Biologics' Construction in Progress had a median value of $92.0 million in 2023 and averaged $68.2 million.
  • In the last 5 years, AbCellera Biologics' Construction in Progress surged by 1340.66% in 2024 and then skyrocketed by 79230.77% in 2025.
  • Quarter analysis of 3 years shows AbCellera Biologics' Construction in Progress stood at $91.0 million in 2023, then rose by 13.41% to $103.2 million in 2024, then increased by 15.02% to $118.7 million in 2025.
  • Its Construction in Progress stands at $118.7 million for Q3 2025, versus $116.0 million for Q2 2025 and $108.6 million for Q1 2025.